Physician profile
Morris E Brown
NPI 1801992599
$1,798.29
in general payments reported to CMS, 2019-2025
9 companies · $241 in 2025
The $241 reported for 2025 was more than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $112 · 2020: $11.02 · 2021: $284 · 2022: $328 · 2023: $215 · 2024: $607 · 2025: $241.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,063.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,062.97 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals Lp | $780.21 | 2019-2025 | Farxiga, Breztri, Airsupra |
| Novo Nordisk INC | $367.70 | 2019-2025 | Ozempic |
| Abbvie INC. | $216.45 | 2022-2023 | Vraylar |
| Abbott Laboratories | $149.77 | 2024 | Navitor |
| Bayer Healthcare Pharmaceuticals INC. | $104.01 | 2022 | |
| Exact Sciences Corporation | $79.40 | 2024 | Cologuard Collection Kit |
| Amgen INC. | $47.19 | 2021 | |
| Phathom Pharmaceuticals, INC. | $28.85 | 2024 | Voquezna |
| Mannkind Corporation | $24.71 | 2019-2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Morris Brown listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.